OneLAX SENNA 417.12 mg/237mL Syrup — NDC 17856-1127-4 (Billing 17856-1127-04)
This is a package of OneLAX SENNA 417.12 mg/237mL Syrup from ATLANTIC BIOLOGICALS CORP., first listed with the FDA Feb 2024 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 17856-1127-4 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 17856 labeler · 1127 product · 4 package
- Package marketed since
- Mar 5, 2024
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 1785611274 1
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 002922
- GCN: 08660
- HICL (First Databank): 001289
- AHFS class code: 56:12.00.00
- RxCUI (RxNorm): 702311
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Contact laxatives class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
- Senna is an over-the-counter laxative for occasional constipation. It's meant for short-term relief, not as an everyday habit.
- It generally produces a bowel movement in about 6 to 12 hours. That's why it's usually taken at bedtime.
- Preferably at bedtime, or as your doctor directs. Shake liquid forms well first, and don't go over the recommended dose on your product's label.
- Don't use laxatives longer than 1 week unless a doctor tells you to. If constipation continues, check in with your doctor.
Patient education
Drug interactions
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 17856-1127-01 17856-1127-1 Main listing | 120 SYRINGE in 1 BOX, UNIT-DOSE / 2.5 mL in 1 SYRINGE Inner NDC 17856-1127-5 · each syringe (2.5 mL) | 2024-03-05 | — | Active |
| 17856-1127-02 17856-1127-2 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 5 mL in 1 CUP, UNIT-DOSE Inner NDC 17856-1127-6 · each unit-dose cup (5 mL) | 2024-03-05 | — | Active |
| 17856-1127-03 17856-1127-3 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 10 mL in 1 CUP, UNIT-DOSE Inner NDC 17856-1127-7 · each unit-dose cup (10 mL) | 2024-03-05 | — | Active |
| 17856-1127-04 You're viewing this | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 15 mL in 1 CUP, UNIT-DOSE Inner NDC 17856-1127-8 · each unit-dose cup (15 mL) | 2024-03-05 | — | Active |
| 17856-1127-09 17856-1127-9 | 120 SYRINGE in 1 BOX, UNIT-DOSE / 2.5 mL in 1 SYRINGE | 2025-12-29 | — | Active |
Pack size FAQ
What quantity is in this package?
What NDC number is used to bill for this package of OneLAX SENNA 417.12 mg/237mL Syrup?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Senna Liquid 8.8 mg/5mL 00536-1266-59 | RUGBY | 237 ml | $0.037 | — | Availability likely | — |
| Senna 8.8 mg/5mL 39328-0020-08 | Patrin | 237 ml | $0.037 | — | Availability likely | — |
| Senna Syrup 8.8 mg/5mL 54859-0808-08 | Llorens | 237 ml | $0.037 | — | Availability likely | — |
| Senna Syrup 8.8 mg/5mL 57237-0301-24 | Rising | 237 ml | $0.037 | — | Availability likely | — |
| Senna Syrup 8.8 mg/5mL 58657-0518-08 | Method | 237 ml | $0.037 | — | Availability likely | — |
| Senna 8.8 mg/5mL 82568-0024-08 | AARNA | 237 ml | $0.037 | — | Availability likely | — |
| Senna 8.8 mg/5mL 00121-4967-40 | PAI | 10 cups | — | — | FDA listed | — |
| Senna 8.8 mg/5mL 00536-1483-59 | Rugby | 237 ml | — | — | FDA listed | — |
| Senna 8.8 mg/5mL 00904-7528-94 | Major | 10 cups | — | — | FDA listed | — |
| OneLAX SENNA 417.12 mg/237mLthis 17856-1127-04 | ATLANTIC | 72 cups | — | — | FDA listed | — |
| OneLAX SENNA 417.12 mg/237mL 17856-8127-02 | Atlantic | 50 cups | — | — | FDA listed | — |
| Senna UD 8.8 mg/5mL 39328-0120-50 | Patrin | 10 cups | — | — | FDA listed | — |
| Senna UD 26.4 mg/15mL 39328-0220-50 | Patrin | 10 cups | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 48433-0219-40 | Safecor | 40 cups | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 50268-0731-24 | AVPAK | 24 cups | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 57237-0310-54 | Rising | 40 cups | — | — | FDA listed | — |
| GeriCare Senna Syrup 8.8 mg/5mL 57896-0472-08 | Geri-Care | 237 ml | — | — | FDA listed | — |
| Senna 8.8 mg/5mL 60687-0851-77 | American | 10 cups | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 63629-9268-01 | Bryant | 237 ml | — | — | FDA listed | — |
| SENNA Syrup 8.8 mg/5mL 66424-0562-08 | SDA | 236 ml | — | — | FDA listed | — |
| Senna 417.12 mg/237mL 68094-0049-62 | Precision | 10 cups | — | — | FDA listed | — |
| Senna 8.8 mg/5mL 69618-0069-58 | Reliable | 237 ml | — | — | FDA listed | — |
| OneLAX SENNA 417.12 mg/237mL 71399-0027-08 | Akron | 237 ml | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 72090-0022-01 | Pioneer | 237 ml | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 72162-1672-02 | Bryant | 237 ml | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 73564-0812-08 | Aldama | 1 bottle | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 81033-0120-50 | Kesin | 50 cups | — | — | FDA listed | — |
| Senna Syrup 8.8 mg/5mL 84415-0021-01 | Everpharm | 100 cups | — | — | FDA listed | — |
| Senna Liquid 8.8 mg/5mL 84447-0120-01 | Belleview | 200000 ml | — | — | FDA listed | — |
| Senna 417.12 mg/237mL 17856-8237-01 | ATLANTIC | 72 cups | — | — | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Senna inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII A2I8C7HI9T
Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII Z8IX2SC1OH
Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
-
UNII C151H8M554
A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
5 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from ATLANTIC BIOLOGICALS CORP. labeler code 17856
- GNP Regular Strength Gas Relief DIMETHICONE 80 mg Tablet, Chewable NDC 17856-1118-1
- MAX relief junior Grape Childrens Acetaminophen 160 mg/5mL Liquid NDC 17856-1122-1
- MAX relief junior Grape Childrens Acetaminophen 160 mg/5mL Liquid NDC 17856-1123-1
- Metamucil Therapy for regularity Psyllium Husk 3.4 g/5.8g Powder NDC 17856-1124-1
- MAX relief junior Grape Childrens Acetaminophen 160 mg/5mL Liquid NDC 17856-1125-1
- MAX Tussin Cough and Chest Congestion DM Sugar Free Dextromethorphan HBr, Guaifenesin 20 mg/10mL; 200 mg/10mL Liquid NDC 17856-1126-1
- SPIRONOLACTONE 25 mg/5mL Suspension NDC 17856-1133-1
- Potassium Chloride Extended-release 1500 mg Tablet, Extended Release NDC 17856-1135-1
- TEENY TUMMY Gas Relief Drops Simethicone 20 mg/.3mL Suspension NDC 17856-1141-1
- TEENY TUMMY Gas Relief Drops Simethicone 20 mg/.3mL Suspension NDC 17856-1142-1
- Mucus Relief DM Extended Release Caplets Guaifenesin, Dextromethorphan HBr 600 mg; 30 mg Tablet, Extended Release NDC 17856-1162-1
- Lithium 8 meq/5mL Solution NDC 17856-1172-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Directions take preferably at bedtime or as directed by a doctor. Shake Well Before Using.
⏱️ Dosage and Administration ▾
age starting dose maximum dosage Adults and children 12 yeart and older 2-3 teaspoons once a day 3 teaspoons twice a day Children 6 years to under 12 yeart 1 - 1 1/2 teaspoons once a day 1 1/2 teaspoons twice a day Children 2 years to under 6 yeart l/2 - 3/4 teaspoon once a day 3/4 teaspoon twice a day Children under 2 years ask a doctor ask a doctor
⚠️ Warnings ▾
Warnings ask a doctor before use if you have • stomach pain • nausea • vomiting • noticed a sudden change in bowel movements that continues over a period of 2 weeks Do not use laxative products for longer than 1 week unless directed by a doctor Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two more hours before or after other drugs. Laxatives may affect how other drugs work.
Stop use and ask a doctor if you have rectal bleeding or fail to have bowel movement after use of laxative. This may indicate a serious condition. If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other Information Avoid accessive heat. Store at room temperature 15°-30°C (59°-86°F)
🧪 Active Ingredient ▾
Active Ingredient Active ingredient (in each teaspoonful) Purpose Sennosides 8.8 mg …………………………................Laxative
🧪 Inactive Ingredients ▾
Inactive Ingredients flavor choclate, mythylparaben, propylene glycol, propylparaben, purified water and sucrose
🎯 Purpose ▾
Uses relieves occasional constipation (irregularity), generally causes bowel movement in 6 to 12 hours
📄 Ask a Doctor Before Use If ▾
Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two more hours before or after other drugs. Laxatives may affect how other drugs work.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if you have rectal bleeding or fail to have bowel movement after use of laxative. This may indicate a serious condition.
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.
KEEP OUT OF REACH OF CHILDREN SECTION In case of accidental overdose, get medical help or contact a Poison Control Center immediately Questions? To Report Adverse Drug Event Call 1(877) 225-6999 DISTRIBUTED BY: ATLANTIC BIOLOGICALS CORP. MIAMI, FL 33179
📄 Package Label / Principal Display Panel ▾
1 LABEL 2 LABEL 3 9
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |